Fukumoto, Y.; Suzuki, N.; Hara, R.; Tanaka, Y.-k.; Ogra, Y.
Development of a Biosafety Level 1 Cellular Assay for Identifying Small-Molecule Antivirals Targeting the Main Protease of SARS-CoV-2: Evaluation of Cellular Activity of GC376, Boceprevir, Carmofur, Ebselen, and Selenoneine. Int. J. Mol. Sci. 2024, 25, 5767.
https://doi.org/10.3390/ijms25115767
AMA Style
Fukumoto Y, Suzuki N, Hara R, Tanaka Y-k, Ogra Y.
Development of a Biosafety Level 1 Cellular Assay for Identifying Small-Molecule Antivirals Targeting the Main Protease of SARS-CoV-2: Evaluation of Cellular Activity of GC376, Boceprevir, Carmofur, Ebselen, and Selenoneine. International Journal of Molecular Sciences. 2024; 25(11):5767.
https://doi.org/10.3390/ijms25115767
Chicago/Turabian Style
Fukumoto, Yasunori, Noriyuki Suzuki, Reina Hara, Yu-ki Tanaka, and Yasumitsu Ogra.
2024. "Development of a Biosafety Level 1 Cellular Assay for Identifying Small-Molecule Antivirals Targeting the Main Protease of SARS-CoV-2: Evaluation of Cellular Activity of GC376, Boceprevir, Carmofur, Ebselen, and Selenoneine" International Journal of Molecular Sciences 25, no. 11: 5767.
https://doi.org/10.3390/ijms25115767
APA Style
Fukumoto, Y., Suzuki, N., Hara, R., Tanaka, Y.-k., & Ogra, Y.
(2024). Development of a Biosafety Level 1 Cellular Assay for Identifying Small-Molecule Antivirals Targeting the Main Protease of SARS-CoV-2: Evaluation of Cellular Activity of GC376, Boceprevir, Carmofur, Ebselen, and Selenoneine. International Journal of Molecular Sciences, 25(11), 5767.
https://doi.org/10.3390/ijms25115767
